{"ORPHApacket":[{"ORPHApacketID":"79172","date":"2019-12-06 08:56:48","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"79172","Name":[{"lang":"en","label":"Creatine deficiency syndrome"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_79172","DisorderType":[{"Name":[{"lang":"en","label":"Clinical group"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377794"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Disorder of energy metabolism"}],"ORPHA":"79200","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_79200"},{"Name":[{"lang":"en","label":"Energy metabolism disorder with epilepsy"}],"ORPHA":"225696","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_225696"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Creatine deficiency syndrome (CDS) comprises a group of inborn errors of creatine metabolism, characterized by a global developmental delay, intellectual disability and associated neurological (seizures, movement disorders, myopathy) and behavioral manifestions. CDS includes two creatine biosynthesis disorders; guanidinoacetate methyltransferase deficiency and L- Arginine: glycine amidinotransferase deficiency, as well as X-linked creatine transporter deficiency."}],"AverageAgeOfOnsetList":[{"count":"2","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Childhood"}]},{"Name":[{"lang":"en","label":"Infancy"}]}]}],"TypeOfInheritanceList":[{"count":"3","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal recessive"}]},{"Name":[{"lang":"en","label":"Not applicable"}]},{"Name":[{"lang":"en","label":"X-linked recessive"}]}]}],"SynonymList":[{"count":"3","Synonym":[{"lang":"en","label":"CCDS"},{"lang":"en","label":"CDS"},{"lang":"en","label":"Cerebral creatine deficiency syndrome"}]}]}]}